1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)
Treatment and conditionWhere it standsTrials
1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study) for parkinson diseaseTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1